A novel PAX 5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX 5

We report a novel t(7;9)(q11;p13) translocation in 2 patients with B-cell acute lymphoblastic leukemia (B-ALL). By fluorescent in situ hybridization and 3 rapid amplification of cDNA ends, we showed that the paired box domain of PAX5 was fused with the elastin (ELN) gene. After cloning the full-length cDNA of the chimeric gene, confocal microscopy of transfected NIH3T3 cells and Burkitt lymphoma cells (DG75) demonstrated that PAX5-ELN was localized in the nucleus. Chromatin immunoprecipitation clearly indicated that PAX5-ELN retained the capability to bind CD19 and BLK promoter sequences. To analyze the functions of the chimeric protein, HeLa cells were cotransfected with a luc-CD19 construct, pcDNA3-PAX5, and with increasing amounts of pcDNA3-PAX5-ELN. Thus, in vitro, PAX5-ELN was able to block CD19 transcription. Furthermore, real-time quantitative polymerase chain reaction (RQ-PCR) experiments showed that PAX5ELN was able to affect the transcription of endogenous PAX5 target genes. Since PAX5 is essential for B-cell differentiation, this translocation may account for the blockage of leukemic cells at the pre–B-cell stage. The mechanism involved in this process appears to be, at least in part, through a dominantnegative effect of PAX5-ELN on the wildtype PAX5 in a setting of PAX5 haploinsufficiency. (Blood. 2007;109:3417-3423)

[1]  G. Delsol,et al.  SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling. , 2006, Blood.

[2]  J. Buerstedde,et al.  Loss of Pax5 promotes plasma cell differentiation. , 2006, Immunity.

[3]  M. Busslinger,et al.  Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. , 2006, Immunity.

[4]  E. Campo,et al.  Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells , 2004, Oncogene.

[5]  M. König,et al.  PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13) , 2003, Leukemia.

[6]  M. Schebesta,et al.  Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. , 2002, Immunity.

[7]  M. Schebesta,et al.  Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. , 2002, Immunity.

[8]  K. Grzeschik,et al.  The elastin gene is disrupted in a family with a balanced translocation t(7;16)(q11.23;q13) associated with a variable expression of the Williams-Beuren syndrome , 2002, European Journal of Human Genetics.

[9]  C. J. Evans,et al.  Combinatorial regulation of the murine RAG-2 promoter by Sp1 and distinct lymphocyte-specific transcription factors. , 2002, Molecular immunology.

[10]  Gouri Nanjangud,et al.  Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas , 2001, Nature.

[11]  L. Kearney,et al.  The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. , 2001, Cancer research.

[12]  C. J. Chen,et al.  PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. , 2000, Science.

[13]  D. Chitayat,et al.  De novo 46,XX,t(6;7)(q27;q11;23) associated with severe cardiovascular manifestations characteristic of supravalvular aortic stenosis and Williams syndrome. , 2000, American journal of medical genetics.

[14]  T. Libermann,et al.  AML1 (CBFα2) Cooperates with B Cell-specific Activating Protein (BSAP/PAX5) in Activation of the B Cell-specific BLK Gene Promoter* , 1999, The Journal of Biological Chemistry.

[15]  P. Gruss,et al.  Pax genes and their role in organogenesis. , 1999, Cancer research.

[16]  M. Busslinger,et al.  Independent regulation of the two Pax5 alleles during B-cell development , 1999, Nature Genetics.

[17]  A. M. Morrison,et al.  Identification of BSAP (Pax‐5) target genes in early B‐cell development by loss‐ and gain‐of‐function experiments , 1998, The EMBO journal.

[18]  M. Busslinger,et al.  Essential functions of Pax-5 (BSAP) in pro-B cell development. , 1997, Immunobiology.

[19]  R. Balling,et al.  Pax genes and organogenesis , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  M. Busslinger,et al.  Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Busslinger,et al.  C‐terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax‐5), Pax‐2 and Pax‐8. , 1996, The EMBO journal.

[22]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[23]  E. Wagner,et al.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP , 1994, Cell.

[24]  J. Biegel,et al.  Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.

[25]  C A Morris,et al.  Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. , 1994, The Journal of clinical investigation.

[26]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[27]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[28]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[29]  Colleen A. Morris,et al.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.

[30]  Pavel Urbánek,et al.  Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9 , 1993, Nature Genetics.

[31]  A. Aguzzi,et al.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. , 1992, Genes & development.

[32]  P Gruss,et al.  Pax: a murine multigene family of paired box-containing genes. , 1991, Genomics.

[33]  L. Sandberg,et al.  Molecular Model for Elastin Structure and Function , 1973, Nature.

[34]  R. Anwar,et al.  On the mechanism of formation of desmosine and isodesmosine cross-links of elastin. , 1970, Journal of the American Chemical Society.

[35]  Minoru Toyota,et al.  Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. , 2003, Cancer research.

[36]  Stephen L. Nutt,et al.  Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 , 1999, Nature.

[37]  R. Dalla‐Favera,et al.  The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. , 1996, Blood.